ArticleFrontiers in pharmacology2025
FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry.
Manisha Singh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it